ABSTRACT-The antithrombotic effects of the thromboxane (TX) A2-receptor antagonist and aspirin were determined using a photochemically-induced arterial thrombosis model in the femoral arteries of guinea
Several experimental models of arterial thrombosis associated with endothelial injury have been established. The way of inducing endothelial injury varies among the models, and endothelial injury has been induced mecha nically, chemically or electrically and so on. Injured endo thelial cells become unable to release antithrombotic substances such as prostaglandin 12 (PGI2) or endothelial derived relaxing factor. In parallel to this, thrombogenic substances like thromboxane (TX) A2 or 5-hydroxytrypta mine become dominant, which entails arterial thrombo sis. Matsuno et al. (1) recently modified a model of arteri al thrombosis based on a photochemically-induced reac tion (2) . The thrombus produced in this model is charac terized by its close resemblance to the one that forms in travascularly in peripheral vascular disease clinically (1) .
The platelets from guinea pigs are quite similar to those from humans with regard to their response to agonists and antagonists of the prostaglandins (3) . Therefore, there is fairly general agreement that the guinea pig is a suitable species for evaluating the antithrombotic effect of an agent. Using guinea pigs, several antithrombotic and antiplatelet agents were demonstrated to exhibit preven tive effects on thrombus formation. These agents include TXA2-receptor antagonists (4, 5) , a TXA synthetase inhi bitor (5), aspirin (4) and ticlopidine (5) .
KW-3635 (sodium (E)-11-[2-(5,6-dimethyl-l-benz imidazolyl)ethylidene] -6,11-dihydrodibenz [b, e] oxepine 2-carboxylate monohydrate) is a potent and selective TXA2-receptor antagonist, which has been demonstrated to inhibit the binding of a TXA2 agonist and a TXA2 an tagonist to its receptors (6), TXA2-mediated platelet aggre gation (7) and constriction of various smooth muscle preparations in response to TXA2 (8) . Moreover, KW 3635 exhibits antithrombotic activity as evidenced by its preventive effect on vascular reocclusion after thrombo lysis with tissue-type plasminogen activator (9) . The pur pose of the present study was to determine whether the TXA2-receptor antagonist KW-3635 is effective in this photochemically-induced thrombosis model and to com pare its efficacy with those of BM-13505 (4-[2-(4-chloro benzenesulfonamide)-ethyl]-benzene acetic acid) (7, 8) and aspirin. BM-13505 is a non-prostanoid type TXA2-recep tor antagonist that has nearly the same potency as KW 3635 in guinea pigs. We also examined the relationship between the antithrombotic and antiplatelet potency of these agents.
KW-3635 and BM-13505 were synthesized in our labo ratories. Sodium arachidonate and rose bengal were pur chased from Sigma Chemical Co. (St. Louis, MO, USA). Collagen and aspirin were obtained from Hormon Chemie (Miinchen, Germany) and Nacalai Tesque, Inc.
(Kyoto), respectively. All the drugs were suspended in 0.3% sodium carboxymethylcellulose at an appropriate concentration so as to make its administration volume 5 ml suspension per kg body weight. All the drugs were ad ministered orally 2 hr before the experiment.
Male Hartley guinea pigs weighing 280-400 g (Japan Shizuoka Laboratory Animal Center, Inc., Hamamatsu) were used. Arterial thrombosis was produced with a slight modification of the method of Takiguchi et al. (4) . In brief, a 5-mm segment of the right femoral artery distal to the inguinal ligament was separated carefully, and a pulse doppler flow probe (PDV-20; Crystal Biotech America, Hopkinton, MA, USA) was placed for measuring blood flow. The arterial blood flow was continuously monitored on a pen-recorder (WI-641GC; Nihon Kohden, Tokyo). The irradiation of green light (540 nm, 180,000 lux) (L4887; Hamamatsu Photonics, Hamamatsu) on the right femoral artery proximal to the flow probe was start ed, and then after 10 min, 3 mg/kg (i.v.) rose bengal was infused for 3 min. Green light exposure was continued un til 20 min after the end of rose bengal infusion. The time to complete occlusion was recorded, and the occlusion time of the non-occluded animal was regarded as 20 min. For the analysis of the time to occlusion, the Kruskal Wallis test followed by the Steel multiple comparison test was used. For the analysis of the incidence of occlusion, Fisher's exact probability test was used. P values less than 0.05 were considered to be statistically significant. Antithrombotic effects of the test compounds are shown in Table 1 . In the vehicle-treated group, the blood flow of the irradiated artery was completely diminished within 400 sec, and it did not recover until 1200 sec. In contrast, all three of the compounds tested prolonged the time to occlusion. KW-3635 and BM-13505, both of which are TXA2-receptor antagonists, delayed the throm bus formation at the dose of 10 mg/kg. Aspirin at the doses of 10 and 100 mg/kg prolonged the time to occlu• sion.
In another series of experiments, ex vivo platelet aggre.
gation was determined. Blood was withdrawn from the ab. dominal aorta and mixed with 1/10 volume of 3.8% so. dium citrate. Platelet aggregation was determined by meas. uring the optical density of platelet-rich plasma using ar aggregometer (TE500; Erma Optical Works Co., Ltd.. Tokyo). For the analysis of ex vivo platelet aggregation the Kruskal-Wallis test followed by a Tukey-type multiplf comparison test was used. Figure 1 shows the effects of the test compounds on ex vivo platelet aggregation induced by sodium arachidonate (100 pM) and collagen (3 pg/ml). Sodium arachidonate is converted by cyclooxygenase and TXA synthetase to TXA2, which induces platelet aggregation. In guinea pigs, the aggregatory response to collagen is mainly mediated by TXA2 (10) . All the drugs almost completely suppressed the aggregation induced by sodium arachidonate at the each maximum dose used. Collagen-induced platelet ag gregation was also markedly attenuated by pre-treatment with these drugs.
The minimum effective doses of KW-3635 and BM 13505 to prolong the time to occlusion were 10 mg/kg for both the drugs. These doses corresponded to the mini mum effective doses to inhibit the ex vivo platelet aggrega tion induced by sodium arachidonate, suggesting that the antithrombotic effects of these compounds are dependent on their abilities to inhibit TXA2-mediated platelet aggre gation. A high dose of KW-3635 (30 mg/kg) completely abolished collagen-induced platelet aggregation, which may suggest a possible additional unknown mechanism for this agent in inhibiting platelet aggregation. Treat ment with aspirin also prolonged the time to thrombotic occlusion at the doses inhibiting the ex vivo platelet aggre gation by sodium arachidonate or collagen. These results suggest that the compounds that inhibit TXA2-mediated platelet aggregation could be effective against arterial thrombogenesis.
In the former studies, Takiguchi et al. (4) and Hirata et al. (5) suggested that in guinea pigs, TXA2 and ADP are the main components involved in producing the photo chemically-induced thrombus. The present result is in accordance with their notion that TXA2 is one of the most important mediators in thrombogenesis in guinea pigs.
In summary, the present study demonstrated that KW 3635, a TXA2-receptor antagonist, is effective in the guinea pig model of photochemically-induced thrombo sis. The antithrombotic potency of the agent correlated well with its potency to inhibit TXA2-mediated platelet ag gregation. These results support the notion that TXA2 is an important mediator in the present model of arterial thrombogenesis.
